Skip to main content

$0.010 (0%)

High

$0.01

Low

$0.01

Trades

6

Turnover

$9,598

Volume

959,788
30 June 2023 at 4:10pm
Register to track JAT and receive email alerts.
Subject
JAT Ann: ASX Appendix 2A

JAT Ann: Supplementary Prospectus for Options

JAT Ann: Options Prospectus update

JAT Ann: Final Director's Interest Notice WY

JAT Ann: Resignation of alternate director

JAT Ann: Prospectus for the issue of options

JAT Ann: Change in substantial holding

JAT Ann: Notice of General Meeting/Proxy Form

JAT Ann: Quarterly Activities/Appendix 4C Cash Flow Report

JAT Ann: Amendment to substantial shareholder notice lodged 12.07.22

JAT Ann: Notice under s249D Corporations Act

JAT Ann: Becoming a substantial holder

JAT Ann: Notification of cessation of securities - JAT

JAT Ann: Appointment of CFO

JAT Ann: Cleansing notice

JAT Ann: Application for quotation of securities - JAT

JAT Ann: Change of Director's Interest Notice - Zhan Wang

JAT Ann: Change in substantial holding

JAT Ann: Change of Director's Interest Notice - Crowley

JAT Ann: Company Secretary Appointment

JAT Ann: Top 20 shareholders

JAT Ann: Application for quotation of securities - JAT

JAT Ann: Results of Rights Issue Offer

JAT Ann: Security Class Suspension from Quotation JATO

JAT Ann: Non-renounceable rights issue-attaching options

JAT Ann: Final Director's Interest Notice - Sun

JAT Ann: Initial Director's Interest Notice - Wang

JAT Ann: Initial Director's Interest Notice - Shen

JAT Ann: Results of Meeting

JAT Ann: Board and management changes

JAT Ann: Update - Proposed issue of securities - JAT

JAT Ann: Rights Issue Offer Document

JAT Ann: Cleansing notice

JAT Ann: Proposed issue of securities - JAT

JAT Ann: Non-Renounceable Issue

JAT Ann: Placement Options

JAT Ann: Cancel - Notification regarding unquoted securities - JAT

JAT Ann: Initial Director's Interest Notice - QIANG

JAT Ann: Initial Director's Interest Notice - GONG

JAT Ann: Notification regarding unquoted securities - JAT

JAT Ann: Director Appointments

JAT Ann: Results of Meeting

JAT Ann: Progress with US FDA application

JAT Ann: Letter to shareholders re general meeting

JAT Ann: Notice of General Meeting/Proxy Form

JAT Ann: Letter to shareholders

JAT Ann: Notice of General Meeting/Proxy Form

JAT Ann: MEMBER STATEMENT SECTION 249P CORPORATIONS ACT

JAT Ann: Presentation to Brokers

JAT Ann: Quarterly Activities/Appendix 4C Cash Flow Report

Register to track JAT and receive email alerts.

Similar Companies

BAP
BDA
DLC
FUN
NTD
SNL
TTA